Document kDDKmBkVnxN9qxygd1LkVepGb
2965629
From:
To:
Ce:
Subject: Date: Attachments:
"BEEF chemours.com" restrictiePFAS; [JERIETIiRdemilieutafel.nl"
FW: ?PFAS Projects: F-gases (Norway) and the food industry and packaging (Netherlands) donderdag 24 december 2020 09:11:11
image001.ong
Dear Mr.
Thanks for your involved so far.
Indeed for Pharmaceutical packaging another work package (Medical & Pharmaceuticals)
is likely more appropriate. You could contact
(De Milieutafel: see cc.) or
send here directly the relevant information.
Regarding Electronic packaging: a working package for Electronics will start early next
year. We can keep you in our mind regarding Electronics (packaging).
Best regards,
5.1.2e
rivm.nl
RIVM, Centre for Safety of Substances and Products Antonie van Leeuwenhoeklaan 9 | 3721 MA Bilthoven | The Netherlands P.O. Box 1 | 3720 BA Bilthoven | www.rivm.nl/en www.chemischestoffengoedgeregeld.nl
From:
<JEEEZIR exponent.com>
Sent: woensdag 23 december 2020 18:07
vm nl> To:
CEC
Cc:
EEE chemours.com>
Subject: RE: ?PFAS Projects: F-gases (Norway) and the food industry and packaging
(Netherlands)
Dear
Please can | introduce you to
that represents the fluoropolymer (FP) side of
Chemours' business and is in the final stages of preparing their responses to our
questionnaires. The applications for the FPs include specialist pharmaceutical and
electronics packaging that | believe would be best handled in those projects, rather than
our generic packaging sub-use.
will still provide us with information on generic
packaging.
| would appreciate it if you could respond directly to
on how he can best provide
information to the pharmaceutical and electronics projects.
Many thanks in advance.
2965629
Exponent International Limited
1 Pride Point Drive
Pride park, Derby DE24 8BX
Direct
Email:
exponent.co
www.exponent.com
CONFIDENTIALITY NOTICE: This e-mail transmission (and the attachments accompanying it) is intended only for the use of the intended recipient and may contain confidential information belonging to the sender. If you are not the intended recipient, be aware that any disclosure, copying, dissemination, distribution or use of the contents of this e-mail transmission is strictly prohibited. If you have received this transmission in error, please promptly notify the sender by reply e-mail and then destroy all copies of the transmission.
Registered in England and Wales number: 4234757 VAT Number: GB 785668267
From:
<HEEESECE chemours.com>
Sent: 21 December 2020 14:42
To:
exponent.com>
Subject: [EXTERNAL] RE: ?PFAS Projects: F-gases (Norway) and the food industry and packaging (Netherlands)
Hi EEE
My name is
and | am working on completing the food-related questionnaires for
Chemours. Would you happen to have any availability this week to discuss a couple related items
in order for us to provide the best responses? | am available the rest of today and all afternoon
tomorrow (lI am located in Eastern Savings Time).
| appreciate it, thanks!
0 IL
51.2
m
The Chemours Company
1007 Market Street--626-3
Wilmington, DE 19899
< Chemours' CORPORATE RESPONSIBILITY
CHAMPION
LinkedIn | Twitter | Chemours| .10cx2o0m 30
2965629
See our web page at http://www .chemours.com for a full directory of Chemours sites, staff, services and career opportunities.
This communication is for use by the intended recipient and contains information that may be privileged, confidential or copyrighted under applicable law. If you are not the intended recipient, you are hereby formally notified that any use, copying or distribution of this e-mail, in whole or in part, is strictly prohibited. Please notify the sender by return e-mail and delete this e-mail from your system. Unless explicitly and conspicuously designated as "E-Contract Intended", this e-mail does not constitute a contract offer, a contract amendment, or an acceptance of a contract offer. This e-mail does not constitute a consent to the use of sender's contact information for direct marketing purposes or for transfers of data to third parties.
From:
<BEES cxponent.com>
Sent: Tuesday, December 08, 2020 9:33 AM
cm To:
<HEEErD c.coN .uk>
Subject: ?PFAS Projects: F-gases (Norway) and the food industry and packaging (Netherlands)
|External email. Confirm links and attachments before opening.
Dear Stakeholders,
This is a kind reminder to complete and return the relevant questionnaires | sent you previously as soon as possible, but at latest by the end of this year. | would also like to invite you to indicate your willingness to have a follow up discussion.
Thank you for those of you that have already returned your questionnaire(s) and offered/arranged a follow up discussion. We are working our way through these responses and will be in contact shortly.
Whilst the ECHA Committees are not experts in the many fields of PFAS use that are relevant to this proposed restriction, they do expect to be able to evaluate the case for a restriction on technical grounds, and so will be looking for data to support the arguments made in the proposal. To ensure your responses are of optimal value for our project, we therefore invite you to follow the guidelines below.
yI
Please provide as much detail in your response because statements need to be
substantiated with data on technical constraints, costs, etc. if they are to carry
any weight in the process. To take an example, we have seen the statement
`there are no alternatives' used in several responses, whilst other stakeholders
have stated that alternatives are readily available on the market. Without further
detail we cannot evaluate the merits of either case.
Providing as much detail as possible is particularly important in sectors where
there are non-PFAS alternatives available for certain uses within that sector, but for others you consider that there is no viable substitute. We want to understand
why the use of PFAS might be considered the right option in some niches within a sector whilst in others alternatives are already widely used. Or, if you are a provider of alternatives, why you consider that your alternative is applicable
when others may say that it is not.
We understand that companies may be reluctant to share case-study material that provides this level of information. However, please recall we have systems in place to protect confidentiality, and it is more effective to make your reasoned arguments at this stage in the process, rather than later on. We are happy to sign non-disclosure agreements specific to this work if this would be helpful.
We look forward to receiving your completed questionnaires at the earliest time and following this up with you in January.
2965629
May | also take this opportunity to wish you all a relaxing and refreshing holiday period. Best regards
5.1.2e
Exponent International Limited
1 Pride Point Drive
Pride park, Derby DE24 8BX
Direct
5.1.2e
Mobile
Email: IEEEE exponent.com
www.exponent.com
CONFIDENTIALITY NOTICE: This e-mail transmission (and the attachments accompanying it) is intended only for the use of the intended recipient and may contain confidential information belonging to the sender. If you are not the intended recipient, be aware that any disclosure, copying, dissemination, distribution or use of the contents of this e-mail transmission is strictly prohibited. If you have received this transmission in error, please promptly notify the sender by reply e-mail and then destroy all copies of the transmission.
Registered in England and Wales number: 4234757 VAT Number: GB 785668267
This communication is for use by the intended recipient and contains information that may be privileged, confidential or copyrighted under applicable law. If you are not the intended recipient, you are hereby formally notified that any use, copying or distribution of this e-mail, in whole or in part, is strictly prohibited. Please notify the sender by return e-mail and delete this email from your system. Unless explicitly and conspicuously designated as "E-Contract Intended", this e-mail does not constitute a contract offer, a contract amendment, or an acceptance of a
contract offer. This e-mail does not constitute a consent to the use of sender's contact
information for direct marketing purposes or for transfers of data to third parties.
https://www.chemours.com/en/email-disclaimer